HUT40572A - Process for production of terapeutical preparatives applicable for treatment of virus-infection - Google Patents

Process for production of terapeutical preparatives applicable for treatment of virus-infection

Info

Publication number
HUT40572A
HUT40572A HU291984A HU291984A HUT40572A HU T40572 A HUT40572 A HU T40572A HU 291984 A HU291984 A HU 291984A HU 291984 A HU291984 A HU 291984A HU T40572 A HUT40572 A HU T40572A
Authority
HU
Hungary
Prior art keywords
terapeutical
preparatives
virus
infection
applicable
Prior art date
Application number
HU291984A
Other languages
Hungarian (hu)
Other versions
HU197517B (en
Inventor
Laszlo Csatary
Original Assignee
Laszlo Csatary
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laszlo Csatary filed Critical Laszlo Csatary
Priority to HU842919A priority Critical patent/HU197517B/en
Priority to EP85903869A priority patent/EP0188590A1/en
Priority to PCT/HU1985/000048 priority patent/WO1986000811A1/en
Priority to AU46380/85A priority patent/AU4638085A/en
Publication of HUT40572A publication Critical patent/HUT40572A/en
Publication of HU197517B publication Critical patent/HU197517B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HU842919A 1984-07-30 1984-07-30 Process for production of terapeutical composition applicable against virus infection HU197517B (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
HU842919A HU197517B (en) 1984-07-30 1984-07-30 Process for production of terapeutical composition applicable against virus infection
EP85903869A EP0188590A1 (en) 1984-07-30 1985-07-29 Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same
PCT/HU1985/000048 WO1986000811A1 (en) 1984-07-30 1985-07-29 Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same
AU46380/85A AU4638085A (en) 1984-07-30 1985-07-29 Therepautic preparations fortreatment of certain viral and other diseases and the preparation of the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU842919A HU197517B (en) 1984-07-30 1984-07-30 Process for production of terapeutical composition applicable against virus infection

Publications (2)

Publication Number Publication Date
HUT40572A true HUT40572A (en) 1987-01-28
HU197517B HU197517B (en) 1989-04-28

Family

ID=10961677

Family Applications (1)

Application Number Title Priority Date Filing Date
HU842919A HU197517B (en) 1984-07-30 1984-07-30 Process for production of terapeutical composition applicable against virus infection

Country Status (4)

Country Link
EP (1) EP0188590A1 (en)
AU (1) AU4638085A (en)
HU (1) HU197517B (en)
WO (1) WO1986000811A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292691C (en) * 1986-09-15 1991-12-03 Allen D. Allen Method for the effective treatment of disease conditions in humans associated with htl virus infection
NZ224567A (en) * 1987-05-19 1990-08-28 Yissum Res Dev Co Vaccine against newcastle disease virus comprising a live immunogenic lentogenic or mesogenic strain of newcastle disease virus in combination with a liquid containing a mineral or vegetable oil
DE3816139A1 (en) * 1987-10-17 1989-04-27 Bayer Ag METHOD FOR PRODUCING PARAMUNITY INDUCERS
DE3806565A1 (en) * 1988-03-01 1989-09-14 Deutsches Krebsforsch VIRUS-MODIFIED TUMOR VACCINES FOR THE IMMUNOTHERAPY OF TUMOR METAL KEYS
EP0713397B1 (en) * 1992-03-24 2002-12-11 United Cancer Research Institute Vaccine containing live virus
US5602023A (en) * 1992-03-24 1997-02-11 Csatary; Laszlo K. Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same
ES2196026T3 (en) 1993-04-30 2003-12-16 Wellstat Biologics Corp USE OF NDV IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT CANCER.
US7470426B1 (en) 1997-10-09 2008-12-30 Wellstat Biologics Corporation Treatment of neoplasms with viruses
US20030044384A1 (en) 1997-10-09 2003-03-06 Pro-Virus, Inc. Treatment of neoplasms with viruses
US7780962B2 (en) 1997-10-09 2010-08-24 Wellstat Biologics Corporation Treatment of neoplasms with RNA viruses
MXPA01010393A (en) 1999-04-15 2004-04-02 Pro Virus Inc Treatment of neoplasms with viruses.
US8147822B1 (en) 1999-09-17 2012-04-03 Wellstat Biologics Corporation Oncolytic virus
EP2327764B1 (en) 2009-11-30 2011-12-28 United Cancer Research Institute New clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES284278A1 (en) * 1962-02-01 1963-06-16 Philips Roxane Incorporated A method for selecting a virus (Machine-translation by Google Translate, not legally binding)
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3548054A (en) * 1969-06-06 1970-12-15 Lilly Co Eli Method for improving weight gains and reducing gross lesions in chickens exposed to marek's disease
DK124340B (en) * 1969-11-29 1972-10-09 Takeda Chemical Industries Ltd Method for producing strong attenuated, live Newcastle disease virus vaccine.
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
ZA743771B (en) * 1973-07-19 1975-07-30 M Sevoian Vaccine and preparation thereof
US4049794A (en) * 1974-06-24 1977-09-20 Bayer Aktiengesellschaft Treatment of infections in animals
ZA754725B (en) * 1974-08-01 1976-06-30 H Stickl Preparation for the treatment of infectious diseases, method for the manufacture thereof, and its use
PT70556A (en) * 1978-12-20 1980-01-01 Gist Brocades Nv Vaccines against diseases caused by reo-virus and process for the preparation of those vaccines
US4357320A (en) * 1980-11-24 1982-11-02 Gist-Brocades N. V. Infectious bronchitis vaccine for poultry
JPS58116422A (en) * 1981-12-28 1983-07-11 Green Cross Corp:The Antitumor agent
GB2114438A (en) * 1982-02-05 1983-08-24 Akzo Nv Infectious bronchitis vaccines

Also Published As

Publication number Publication date
WO1986000811A1 (en) 1986-02-13
HU197517B (en) 1989-04-28
AU4638085A (en) 1986-02-25
EP0188590A1 (en) 1986-07-30

Similar Documents

Publication Publication Date Title
HUT38610A (en) Process for production of //alkyl-sulphamido/-phenil/-alkyl-amins
HUT45193A (en) Process for production of galenicum
HUT45096A (en) Process for production of l-lisine
HUT52560A (en) Process for production of plasmide-vectors
HUT37742A (en) Process for production of aril-hydroxamates
HUT43846A (en) Process for production of new microlide compounds
HUT42452A (en) Process for production of new 2-aryl-imidasoles
HUT44976A (en) Process for production of chlor-gas from hydrogenchlorid
BG51051A3 (en) Process for production of b avermektins
HUT39467A (en) Process for production of polimers of vinil chlorid
HUT37628A (en) Process for production of acetil-eritromicin-stearat and medical preparatives containing - as reagent - such compounds
HUT40564A (en) Process for production of medical preparatives applicable for treatment of pathalogical histogenesis
HUT37354A (en) Process for production of medical plaster
HUT44780A (en) Process for production of new indole-derivatives
HUT40438A (en) Process for production of new condensated imidazoderivatives
HUT40572A (en) Process for production of terapeutical preparatives applicable for treatment of virus-infection
HUT51901A (en) Process for production of new trombolitic ensimes
HUT37355A (en) Process for production of plaster-formed medical preparatives
HU194894B (en) Process for production of compounds with antibacteric effect
HUT38540A (en) Process for production of improved anti-inflammatic preparatives
HUT44475A (en) Process for production of chlor-carbonic-acid-chlorids
HUT47223A (en) Process for production of therapeutical composition suitable for treatment of virus-infections
EP0249969A3 (en) Process for production of 1-aminoauthraquinone
HUT49143A (en) Process for production of d-arabinase
HUT38302A (en) Process for production of new derivatives of phenilacetonitril

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
HMM4 Cancellation of final prot. due to non-payment of fee
HRH9 Withdrawal of annulment decision